including remote scheduling and payments, are also likely to have contributed to growth. All these factors are expected to be positively reflected in Henry Schein’s 2024 first-quarter ...

The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as they position themselves for future growth in the competitive diabetes ...